Key result
True mitral stenosis post-TAVI is linked to a ~176% higher risk of poor clinical outcomes.
Why the study?
Predictors and the prognostic value of true degenerative mitral stenosis in patients with aortic stenosis undergoing TAVI were unknown.
What are the predictors of true degenerative mitral stenosis in patients undergoing TAVI, and does true MS affect clinical prognosis?
What are the predictors of true degenerative mitral stenosis in patients undergoing TAVI, and does true MS affect clinical prognosis?
In patients undergoing TAVI, anterior mitral leaflet calcification on CT strongly predicts the presence of true degenerative mitral stenosis, which is associated with a nearly 3-fold increased risk of poor clinical outcomes.
Answers are grounded in this paper and cite their sources.
AML calcification flags true MS with poor post-TAVI prognosis; hypothesis-generating for risk stratification pending prospective validation.
Aims Predictors of true degenerative mitral stenosis (MS) in patients with aortic stenosis who underwent transcatheter aortic valve implantation (TAVI) remain unknown. This study aimed to investigate the predictors and prognostic value of true degenerative MS in this population. Methods and results We retrospectively reviewed the records of 760 consecutive patients who underwent TAVI. The mitral valve area (MVA) was assessed using transthoracic echocardiography, and mitral valve calcification was assessed using multi-detector computed tomography. MS was defined as an MVA of ≤2.0 cm², and true MS was defined as moderate or severe MS following TAVI. In our TAVI cohort, we identified 72 (9.5%) patients with degenerative MS. Among these, true MS was observed in 38 (52.7%) patients. Echocardiographic data showed that the true MS group had a significantly lower MVA and higher trans-mitral gradient. The severity of mitral annular calcification was not significantly different between the two groups; however, the true MS group had significantly more posterior mitral leaflet and anterior mitral leaflet (AML) calcification. Multivariable logistic regression analysis showed that AML calcification was the independent predictor of true MS [adjusted odds ratio, 9.23; 95% confidence interval (CI) 2.84–29.9]. True MS was independently associated with poor prognosis (adjusted hazard ratio, 2.76; 95% CI 1.09–6.98). Conclusion Approximately half of the patients with concomitant degenerative MS who underwent TAVI had true MS, which was associated with a poor prognosis. Computed tomographic analysis of AML calcification was useful for predicting true MS.
No takes yet. Share an insight, caveat, or question.
Yamaga et al. (2024) studied this question. True mitral stenosis (MS) occurred in 52.7% of patients with degenerative MS post-TAVI and was associated with a poor prognosis.
Synapse has enriched 10 related papers. Consider them for comparative context: